Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease
By Jong-Hoon Kim, J. Auerbach, J. A. Rodríguez-Gómez, I. Velasco, Denise K Gavin, N. Lumelsky, Sang‐Hun Lee, John Nguyen, R. Sánchez-Pernaute, K. Bankiewicz and 1 more. Nature, 2002
1,665 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/dc811b3e50ee902fbe6901404e16c01252dfffea
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
- Z. Kokaia
- O. Lindvall
- G. Keller
- G. Martino
- Kenji Mizuseki
- S. Pluchino
- A. Vezzani
- M. Constantine‐Paton
In Molecular Biology
- R. Jaenisch
- G. Keller
- Marius Wernig
- F. Soldner
- M. Constantine‐Paton
- Kenneth R. Boheler
- A. Wobus
- R. Galli
Citations in the corpus
- Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease (2008, methodology): “Following protocols developed for mouse ES cells, we treated FGF2 responsive, iPS cell-derived neural precursor cells with the regional patterning factors sonic hedgehog and FGF8 (23, 27).”
- Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain (2004, background): “In rodents, circling has been linked to striatal neurodegeneration in Huntingtin transgenics (Hodgson et al., 1999) and to drug-induced defects of dopamine supply to the striatum (Kim et al., 2002), indicating the involvement of the basal ganglia-thalamo-cortical circuitry (see Wang et al., 2002).”
- Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor (2004, positive): “HESCs could also be used to generate specific types of tissues for cell replacement therapy as a promising approach to treatment of devastating diseases such as Parkinson disease and diabetes mellitu”
- Directed differentiation of telencephalic precursors from embryonic stem cells (2005, background): “This is the first quantitative report of such efficient in vitro induction of telencephalic precursors from ES cells (qualitative detection of Bf1 induction has also been reporte”
- Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis (2003, background): “This pathological feature prevents the use of a classical neural transplantation approach, in which the therapeutic cells are injected in the proximity of the site of the lesion or into its target area, such as in Parkinson's diseas”
- Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation (2005, background): “…neurons incorporate into the striatum and improve behavioral performance following transplantation into mouse models of Parkinson’s disease (Kim et al., 2002; Nishimura et al., 2003), and mouse embryonic stem cell-derived motor neurons survive and differentiate following transplantation…”
- Stem cell therapy for human neurodegenerative disorders–how to make it work (2004, background): “One advantage with stem cells is the possibility for controlled genetic modification, which, for example, could be used to increase survival, differentiation, migration and function of their progen”
- Mesenchymal stem cells: clinical applications and biological characterization. (2004, background): “Embryonic stem cells are capable of forming dopamine neurons in an animal model of Parkinson’s Disease ( Kim et al., 2002 ).”
- Embryonic stem cell differentiation: emergence of a new era in biology and medicine. (2005, background): “For instance, midbrain dopaminergic neurons have been generated in the EB system by overexpression in the cells of the transcription factor nuclear-receptor-related factor1 (Nurr1), and the addition to the cultures of SHH and FGF8 (Kim et al. 2002).”
- Embryonic stem cells: prospects for developmental biology and cell therapy. (2005, methodology): “Importantly, it is not simply the transplantation of mouse (396) and human (362) ES cells that results in the growth of teratomas, but also the transplantation of ES-derived differentiated cell populations (38, 191).”